Technical Analysis for XBIT - XBiotech Inc.

Grade Last Price % Change Price Change
grade C 9.01 1.01% 0.09
XBIT closed up 1.01 percent on Friday, May 24, 2019, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical XBIT trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 1.01%
BB Squeeze + Lower Band Touch Range Contraction 1.01%
Lower Bollinger Band Touch Weakness 1.01%
20 DMA Resistance Bearish -0.55%
Spinning Top Other -0.55%
Bollinger Band Squeeze Range Contraction -0.55%
20 DMA Resistance Bearish -1.96%

Older signals for XBIT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing “True Human™” monoclonal antibodies for treating various different diseases. Its lead product is Xilonix, which is in II Phase III clinical trials for the treatment of colorectal cancer in the United States and Europe. The company also develops MABp1, a therapeutic antibody, which neutralizes interleukin-1 alpha; and completed a Phase I/II clinical trials for MABp1 as a treatment for cancer. In addition, it investigates MABp1 in clinical trials for other indications, including vascular disease, type II diabetes, acne, and psoriasis. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Biopharmaceutical Cancer Medical Specialties Life Sciences Drugs Antibodies Monoclonal Antibodies Psoriasis Acne Colorectal Cancer Ii Diabetes Vascular Disease Monoclonal Antibody Therapy Treatment For Cancer Mm 151 Treatment Of Colorectal Cancer
Is XBIT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.74
52 Week Low 2.13
Average Volume 122,169
200-Day Moving Average 6.2622
50-Day Moving Average 9.6858
20-Day Moving Average 9.198
10-Day Moving Average 9.148
Average True Range 0.5433
ADX 11.76
+DI 13.7757
-DI 17.4442
Chandelier Exit (Long, 3 ATRs ) 8.330100000000001
Chandelier Exit (Short, 3 ATRs ) 10.204899999999999
Upper Bollinger Band 9.6689
Lower Bollinger Band 8.7271
Percent B (%b) 0.3
BandWidth 10.239182
MACD Line -0.1144
MACD Signal Line -0.0958
MACD Histogram -0.0185
Fundamentals Value
Market Cap 319.13 Million
Num Shares 35.4 Million
EPS -1.46
Price-to-Earnings (P/E) Ratio -6.17
Price-to-Sales 0.00
Price-to-Book 2.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.63
Resistance 3 (R3) 9.61 9.39 9.52
Resistance 2 (R2) 9.39 9.23 9.40 9.49
Resistance 1 (R1) 9.20 9.14 9.30 9.22 9.45
Pivot Point 8.98 8.98 9.03 8.99 8.98
Support 1 (S1) 8.79 8.82 8.89 8.81 8.57
Support 2 (S2) 8.57 8.73 8.58 8.53
Support 3 (S3) 8.38 8.57 8.50
Support 4 (S4) 8.40